SARS-CoV-2

Coronavirus Research Using Next-Generation Sequencing (NGS)

One assay surveying the entire coronavirus genome for epidemiological investigation

A major challenge for microbiologists and virologists is the prediction of patterns of evolution and emergence of disease agents. RNA viruses like the coronavirus share the biological feature of high genetic variability, which causes them to appear as clouds of mutants. Coronavirus variants also emerge through antigenic shift within animal reservoirs, such as bats and snakes.

Our  targeted next-generation sequencing (NGS) enables a streamlined research workflow for complete genome sequencing and epidemiological studies of SARS-CoV-2 (the coronavirus responsible for COVID-19). Through the use of our tested protocol all genomic segments are amplified and the DNA amplicons are sequenced to deliver highly accurate coronavirus typing in under a day.

The  SARS-CoV-2 Research Panel we offer consists of 2 pools with amplicons ranging from 125–275 bp in length for complete viral genome sequencing and variant detection.

  • Fast turnaround time—call us to check our 1 week data delivery option
  • Accuracy of variants covering >99% of the viral genome and variants
  • Higher success rates and increased test eligibility—analyze samples with lower viral loads
  • Low input requirements with PCR-based sensitivity—amplify directly from sample